ATRI News Alert Atrion Corp (ATRI) 332.77 02/14/2015 12:04:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Atrion Corp (ATRI) 332.77 $ATRI

If You Like Johnson & Johnson And Abbott Labs, Then You Should Consider Atrion Corporation
Doug Van Cuyk - at Seeking Alpha - Mon Feb 02, 11:32AM CST

JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), ATRI: 332.77 (-2.85)

Nasdaq stocks posting largest volume increases
AP - Tue Jan 06, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ATRI: 332.77 (-2.85), BRID: 7.55 (-0.04), ASBB: 19.90 (+0.05), WVFC: 11.02 (-0.45), CALI: 1.35 (+0.06), SFST: 17.20 (-0.42), WBB: 16.13 (+0.08), ANTH: 3.84 (+0.06), ANAT: 104.90 (-0.10), BTA: 11.32 (-0.07), FBMS: 14.69 (+0.31), ATHX: 2.12 (unch), STXS: 2.27 (+0.13), PZZI: 7.94 (+0.08)

11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 63.20 (-0.45), SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), USPH: 41.08 (+0.07), ATRI: 332.77 (-2.85), STE: 65.50 (-0.35), GB: 50.86 (+0.20), TFX: 112.07 (+0.47), ICLR: 60.01 (+0.38), CMN: 44.28 (+1.09), UTMD: 58.02 (-0.40)

Suggesting An Entry Point For Atrion
Doug Van Cuyk - at Seeking Alpha - Tue Dec 30, 11:34AM CST

ATRI: 332.77 (-2.85)

Dividend Contenders, Future Champions Or Future Failures: Part 9
Stan Stafford - at Seeking Alpha - Thu Dec 11, 8:26PM CST

WST: 51.35 (+0.57), ATRI: 332.77 (-2.85), MLAB: 73.79 (-1.37)

Atrion's board reports USD0.75 per share dividend
M2 - Mon Nov 17, 6:19AM CST
The board of directors of Atrion (NASDAQ:ATRI), a medical applications company, on Friday declared a quarterly dividend of USD0.75 per share on the company's outstanding shares of its common stock.
ATRI: 332.77 (-2.85)

Atrion declares $0.75 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 10:22AM CST

ATRI: 332.77 (-2.85)

Atrion Corporation Declares Quarterly Cash Dividend
Marketwired - Fri Nov 14, 10:18AM CST
The Board of Directors of Atrion Corporation (NASDAQ: ATRI) today announced its quarterly dividend of 75 cents per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2014 to stockholders of record at the close of business on December 1, 2014.
ATRI: 332.77 (-2.85)

Atrion Corporation: Not Quite A Bargain, But A Company Investors Should Keep On Their Watch List
Boring Stock Lover - at Seeking Alpha - Fri Nov 07, 7:24AM CST

ATRI: 332.77 (-2.85)

Atrion posts unchanged Q3 net income of USD7.7m
M2 - Mon Nov 03, 5:58AM CST
Medical application company Atrion (NASDAQ:ATRI) announced on Friday its diluted earnings per share of USD3.91 for third quarter of 2014.
ATRI: 332.77 (-2.85)

Atrion EPS of $3.91
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:38PM CDT

ATRI: 332.77 (-2.85)

Atrion Reports Third Quarter Results
Marketwired - Fri Oct 31, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter of 2014 revenues totaled $36.6 million compared with $34.0 million for the same period in 2013. Operating income for the just ended quarter was $11.2 million compared to $10.7 million in the same period of 2013. On a diluted per share basis, earnings for the period increased to $3.91 as compared to $3.81 for the same quarter of last year. Net income for the third quarter of $7.7 million was the same in last year's third quarter.
ATRI: 332.77 (-2.85)

Atrion Corporation Increases Quarterly Cash Dividend by 17%
Marketwire - Wed Sep 03, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced an increase in its quarterly cash dividend from 64 cents per share to 75 cents per share. Specifically, the Board of Directors declared a quarterly dividend of 75 cents per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2014 to stockholders of record at the close of business on September 15, 2014.
ATRI: 332.77 (-2.85)

Atrion Reports Second Quarter Results
Marketwire - Wed Aug 06, 3:30PM CDT
Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2014 revenues totaled $35.0 million compared with $32.6 million in the same period in 2013. On a diluted per share basis, earnings for the period increased to $3.48 as compared to $3.22 in the same period of last year. Net income for the second quarter totaled $6.9 million compared to $6.5 million in last year's second quarter.
ATRI: 332.77 (-2.85)

Hyperion Therapeutics Announces the Publication of Phase 2 Results of Glycerol Phenylbutyrate (GPB) for the Treatment of Hepatic Encephalopathy in Hepatology
GlobeNewswire - Tue Feb 25, 9:25AM CST
Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that results of the Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of hepatic encephalopathy (HE) were published in the March 2014 issue of Hepatology. The study met its primary endpoint with significantly fewer patients treated with GPB experiencing HE events as compared to patients receiving placebo.
ATRI: 332.77 (-2.85), HPTX: 26.83 (-0.05)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 20

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 29

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 12

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 19

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 31

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 20

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 14

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 31

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Dr. Anderson’s Journey: Leadership with Faith and Service

Updated Category News Views 8

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 28

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding EREVs: A Pathway to Successful Electrification

Updated Category News Views 195

Understanding EREVs and Their Role in Electrification As the automotive landscape evolves, consumers find themselves at a crossroads, uncertain about the transition to fully battery electric vehicles (BEVs). In this environment, Extended Range Electric Vehicles (EREVs) emerge as a practical alternative, catering to new-car buyers seeking a balance between traditional...

Continue Reading
Dry Chemistry Analyzer Market Expected to Hit USD 33.2 Billion

Updated Category News Views 154

Overview of the Dry Chemistry Analyzer Market The global dry chemistry analyzer market has set a remarkable trajectory, starting with a valuation of USD 15.2 billion, and is projected to reach an impressive USD 33.2 billion in the upcoming years. This growth is fueled by the increasing necessity for effective diagnostic tools that enhance patient outcomes. These analyzers...

Continue Reading
iPower's Strategic Shift Towards Flexible Funding Solutions

Updated Category News Views 159

iPower's Strategic Move for Enhanced Capital Flexibility iPower Inc. (NASDAQ: IPW), a data-driven e-commerce retailer, is making proactive strides to improve its financial flexibility. The company is exploring diverse funding mechanisms to tailor its financial structure to current market dynamics, ultimately boosting liquidity. Transitioning to Non-Bank Financing...

Continue Reading
Netskope Strengthens Leadership with Wes Simons Appointment

Updated Category News Views 121

Netskope Welcomes Wes Simons as Senior Vice President Netskope has officially welcomed Wes Simons to its executive team as the Senior Vice President of North America Sales. This strategic appointment comes as the company seeks to boost its growth in a key market. With more than 25 years of experience in cybersecurity sales, Simons is poised to be a significant asset for...

Continue Reading
Understanding the Recent Rating Change for Nissan Global Reinsurance

Updated Category News Views 188

AM Best Adjusts Nissan Global Reinsurance's Credit Ratings AM Best recently announced a downgrade of the Financial Strength Rating for Nissan Global Reinsurance, Ltd. (NGRe), reducing it to A- (Excellent) from A (Excellent). Alongside this, the Long-Term Issuer Credit Rating has also been adjusted from "a" (Excellent) to "a-" (Excellent). Notably, the outlook for these...

Continue Reading